Davis Blaine

Davis Blaine is listed in filings as Chief Financial Officer at Cartesian Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 8, 2026, including sale activity. Recent filings connect the profile to Cartesian Therapeutics, Inc. (RNAC). The current snapshot covers public activity from Jan 6, 2025 to Jan 8, 2026. Reported amounts are shown as $72.2K to $67.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.